Share Name Share Symbol Market Type Share ISIN Share Description
Eden LSE:EDEN London Ordinary Share GB0001646941 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 12.25p 11.50p 13.00p 12.25p 12.25p 12.25p 0 05:00:01
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 1.9 -0.8 -0.3 - 25.38

Eden Share Discussion Threads

Showing 5401 to 5425 of 5425 messages
Chat Pages: 217  216  215  214  213  212  211  210  209  208  207  206  Older
DateSubjectAuthorDiscuss
16/11/2018
20:27
Eden has 27 days to deliver on what it has been promising to deliver.Unlike our Prime Minister, directors should consider their positions if they fail to deliver.
northwick
16/11/2018
13:05
Has a share price and volume traded ever been more subdued with such a large list of news due and game changing news in the next 6 weeks. Really quite remarkable. I do hope Shore Capital will seriously raise their game with these announcements, otherwise be sacked and replaced by a broker who better understands Eden, has more faith & interest in Eden, is prepared to work for Eden and their shareholders! A List of News Due by 31/12/2018 In no particular order 1) USA distributor for Mevalone 2) Toll manufacturing in ...Brazil 3) Possible update from Eden/Eastman on Cedroz 4) Sipcam new territories 5) Sipcam licence extensions 6) Sipcam/Eden new pipeline products 7) Sipcam success on encapsulation of up to 21 of their own current commercial pesticides 8) Sipcam co-encapsulation of their own pesticides with Eden's active ingredients 9) Milestone and other payments from Sipcam 10) Bayer launch of 4 animal health products in the USA 11) European distributor for Eden/TT's head lice product 12) UK launch date for Eden/TT's head lice product 13) TT launch of Deodorant 14) Update by Eden of TT developed products using Eden's Sustaine technology 15) Possible European distributor for 4 animal health care products in Europe 16) Sipcam potential appointee to the board of Eden 17) Chairman's purchase of Eden shares as indicated at the June 2018 AGM 18) Eden update on patents 19) End of year sales indication (late December if as before) MOST, but not all of this is due before 31/12/2018 as previously RNS'd and mentioned at this year's AGM Also, I suspect and as discussed at the AGM, a valuation on the Company (Edison, Hardman, ANO)
investingisatrickygame
14/11/2018
14:26
Testudinal eden... has the race started??
bjlk
14/11/2018
14:06
hxxp://mentalfloss.com/article/56805/16-fun-facts-about-tortoises 8 & 16 maybe :) :)
investingisatrickygame
14/11/2018
13:31
And the tortoise was amazed at how much tumbleweed and silence there was in the imminent time period
bjlk
13/11/2018
17:00
'What has she got that we do not have?' Said the Tortoise to the Hare:)
supersonico
13/11/2018
16:27
You could be right Super. Nonetheless, Marrone's business is worth $200 million, ours just £25 million? What has she got that we do not have? Alternatively, what do we have that Eden is not sharing or promoting to at least put us on an equal Mcap footing? Marrone Bio Innovations 57 0f 193 hxxps://investors.marronebio.com/static-files/245cc678-4d90-41da-abf7-e84ac5873de4 'Historically, we have funded our operations from the issuance of shares of common stock, preferred stock, warrants and convertible notes, the issuance of debt and entry into financing arrangements, product sales, payments under strategic collaboration and distribution agreements and government grants, but we have experienced significant losses as we invested heavily in research and development. We expect to incur additional losses related to our investment in the continued development, expansion and marketing of our product portfolio. Read page 72 of 193 84 of 193 "The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 1 to the consolidated financial statements, the Company’s historical operating results and negative working capital indicate substantial doubt exists about the Company’s ability to continue as a going concern. Management’s evaluation of the events and conditions and management’s plans regarding these matters also are described in Note 1. The consolidated financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result from the outcome of this uncertainty." 55'
investingisatrickygame
13/11/2018
15:51
I would not say 'strung us along' more get the Ducks in a long line.. they imo have had to coordinate and navigate Patent protection, licences , trials and regulators and partners all the while evolving the 'Sustaine' message. I could be way off but I expect a big Sustain Global Launch in 2019 which will bring together much of what is atm described as being in the Consumer Health and Animal Health 'pipeline'. This may well have not been the plan all along but things change and opportunities present themselves as well as obstacles, that's why I think this plan may well have evolved into a 2019 Launch over many years. All guesses all the time.
supersonico
13/11/2018
15:13
So super what your saying is they strung us lth along to keep the company going , and now they have prepared a huge boom to relaunch Eden and it's just going to happen... has not the market been strung along all these years and have they not heard cry wolf a few too many times as well??It better be a huge boom and a massive relaunch and declaring the extinction of wolves??I see where you're going , I am prepared to eat my hat..
bjlk
13/11/2018
14:38
The Question I would ask is... Why are they not? 2015..in the coming months got us to 2016 2016..in the coming months got us to 2017 2017..in the coming months got us to 2018 2018..in the coming months got us to June 2018 June 2018..in short order/ Shelf life got us to Sept 2018 Sept 2018..New school year..gets us to Jan 2019. Jan 2019..Sustaine Brand and multi product PR Launch. imho
supersonico
13/11/2018
14:28
Shouldn't they at least try and inspire the investment case a little...
bjlk
13/11/2018
14:27
#2019SustaineCommerciallaunch. Yes, I would anticipate seeing something in this respect and in short order.
investingisatrickygame
13/11/2018
14:14
Investing, They are not very good at it atm because they either don't want to or don't need to imo or NDA. I'm sure Lykele or Lofty Dibbers could work out how if need be. #2019SustaineCommerciallaunch.
supersonico
13/11/2018
14:07
Super said "I think plenty of PR will come from Eastman when they are ready to market the products." I have no doubt about that, but that will be to growers, farmers, industry players. It is Eden's job and total responsibility to get the correct and understood messages out to investors. Something they are really not very good at, even if they have great products, great IP and great industry partners, commercialised or about to be.
investingisatrickygame
13/11/2018
13:22
I think plenty of PR will come from Eastman when they are ready to market the products. Same for Bayer etal.
supersonico
13/11/2018
12:48
Big industry recognition with a huge partner and we get this huge damp squib from the company...We are here to make money and further great tech but it staggers me that they seem ok with not highlighting anything of what they're doing or getting the story out there and building momentum etcThey have till year end for me, then I will reconsider my position The story will not sell itself, where is all this PR etc...
bjlk
13/11/2018
12:03
They haven't explained what it means. That is my main point
investingisatrickygame
13/11/2018
10:24
1) USA distributor for Mevalone 2) Toll manufacturing in ...Brazil 3)# RNS 13/11/18 Possible best new bio product award for Cedroz (Monday 12th November) 4) Possible update from Eden/Eastman on Cedroz 5) Sipcam new territories 6) Sipcam licence extensions 7) Sipcam/Eden new pipeline products 8) Sipcam success on encapsulation of up to 21 of their own current commercial pesticides 9) Sipcam co-encapsulation of their own pesticides with Eden's active ingredients 10) Milestone and other payments from Sipcam 11) Bayer launch of 4 animal health products in the USA 12) European distributor for Eden/TT's head lice product 13) UK launch date for Eden/TT's head lice product 14) TT launch of Deodorant 15) Update by Eden of TT developed products using Eden's Sustaine technology 16) Possible European distributor for 4 animal health care products in Europe Sipcam potential appointee to the board of Eden 17) Chairman's purchase of Eden shares as indicated at the June 2018 AGM Eden update on patents 18) End of year sales indication (late December if as before)
supersonico
13/11/2018
10:20
It was RNS Reach : https://www.londonstockexchange.com/exchange/prices-and-markets/stocks/exchange-insight/company-news.html?fourWayKey=GB0001646941GBGBXASQ1
mirandaj
13/11/2018
10:17
I agree the RNS doesn't really say anything to the casual observer. Facts figures and revenue are what's needed. Or, a constant stream of this type of RNS to build the story and positivity.
timbo_slice
13/11/2018
09:37
The RNS:http://otp.investis.com/clients/uk/eden_research/rns/regulatory-story.aspx?cid=2240&newsid=1206964 The purpose of RNS:https://www.londonstockexchange.com/products-and-services/rns/about/rns-remove.htm The purpose of RNS Reach: https://www.londonstockexchange.com/products-and-services/rns/rns-reach/rns-reach.htm RNS Reach is what should have been released. The RNS reads more like an industry announcement rather than a call to action to shareholders and investors. IF you're going to release an RNS, say what it means! What does it mean that Cedroz has been 'commended' at the 'prestigious Agrow Awards?' If you can't say to shareholders and investors, whom the RNS channel is reaching out to, what it means, then no need to say anything at all via RNS. Simply use your twitter account for your industry folk and send an email from your web address for those who have opted in!!!!!!!!!!!!!!!!
investingisatrickygame
13/11/2018
08:43
Tobacco, Sweet potato or Silver leaf whitefly Bemisia tabaci hTTps://agronotizie.imagelinenetwork.com/difesa-e-diserbo/2018/11/07/autorizzazione-in-deroga-per-verimark-2018/60704 There is a growing need for effective formulations against aleurodides. In this sense we propose Cyazypyr ™, a registered name of the active substance cyantraniliprole, a new cross-spectrum insecticide belonging to the anthra-amanamide chemical family. Classified in group 28 IRAC, it exerts its action on the ryanodine receptors of the muscle fibers of insects. This interferes with the metabolism of calcium ions in the smooth and striated muscles, thus leading the insect to death by paralysis. Cyazypyr ™ is effective on parasitic pungent mouth sucking parasites, such as aphids and aleurodides, but also thrips, while also controlling insects with a chewing apparatus such as beetles and lepidopterans. Characterized by a favorable toxicological and ecotoxicological profile, Cyazypyr ™ has a wide spectrum of action, showing a marked biological activity against numerous parasites, including the aphid of cotton and cucurbitaceae, Aphis gossypii. Among the aphid of cucurbits, A. gossypii appears in fact one of the most widespread and harmful species for horticultural crops. hTTps://planthealthportal.defra.gov.uk/assets/factsheets/Bemisia-tabaci-Defra-Plant-Pest-Factsheet-Feb-2017-2.pdf
supersonico
13/11/2018
08:33
Sean Smith with Eastman's Emanuele Medico @ Agrow Awards18 hTTps://twitter.com/EastmanChemCo
supersonico
13/11/2018
07:54
Double post!
wan
13/11/2018
07:54
Thanks Mirandaj, indeed Eden gets an important mention - “I would like to extend my gratitude to all Eastman colleagues involved in the development of Cedroz, for their dedication and hard work,” said Guy Van Den Bossche, General Manager Crop Protection at Eastman. “My thanks and appreciation also go to Eden Research plc, who formulated the product; and last but not least, to the growers involved in the many trials we have done, without whom we would not be here today.”
wan
Chat Pages: 217  216  215  214  213  212  211  210  209  208  207  206  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:42 V: D:20181118 16:15:18